respiratori
syncyti
viru
rsv
highli
pathogen
member
paramyxovirida
caus
sever
respiratori
tract
infect
report
literatur
indic
infect
cell
incom
virus
either
fuse
envelop
directli
plasma
membran
exploit
clathrinmedi
endocytosi
studi
entri
process
human
tissu
cultur
cell
hela
use
fluoresc
microscopi
develop
quantit
facsbas
assay
follow
viru
bind
cell
endocytosi
intracellular
traffick
membran
fusion
infect
varieti
perturb
employ
character
cellular
process
involv
found
immedi
bind
cell
rsv
activ
signal
cascad
involv
egf
receptor
downstream
effector
led
seri
dramat
actin
rearrang
cell
round
plasma
membran
bleb
form
signific
increas
fluid
uptak
effect
inhibit
use
compound
target
na
h
exchang
myosin
ii
factor
infect
observ
rsv
rapidli
effici
intern
actindepend
process
hallmark
macropinocytosi
rather
fuse
plasma
membran
virus
thu
enter
fluidfil
macropinosom
fuse
membran
averag
min
intern
requir
infect
find
explan
endocytosi
requir
unusu
among
paramyxovirus
analyz
fusion
protein
f
could
show
although
alreadi
cleav
furin
famili
proteas
underw
second
critic
proteolyt
cleavag
intern
cleavag
furinlik
proteas
remov
small
peptid
subunit
made
viru
infecti
human
respiratori
syncyti
viru
rsv
belong
paramyxovirida
famili
envelop
virus
negativestrand
rna
genom
ubiquit
human
pathogen
caus
sever
respiratori
tract
infect
affect
mainli
children
elderli
worldwid
despit
ongo
effort
avail
vaccin
treatment
except
passiv
immunoprophylaxi
better
understand
virushost
cell
interact
critic
develop
new
therapeut
strategi
rsv
particl
produc
tissu
cultur
heterogen
size
shape
round
diamet
nm
other
filament
length
mm
nucleocapsid
helic
contain
addit
rna
nucleoprotein
n
viral
polymeras
l
cofactorphosphoprotein
p
transcript
process
factor
matrix
protein
believ
form
layer
insid
viral
envelop
lipid
envelop
deriv
plasma
membran
pm
infect
host
cell
contain
three
viral
glycoprotein
major
attach
protein
g
fusion
protein
f
small
hydrophob
protein
sh
cell
attach
rsv
mediat
g
f
bind
cellular
glycosaminoglycan
g
sh
essenti
replic
cell
cultur
indic
f
protein
support
attach
fusion
vivo
rsv
target
airway
epitheli
cell
human
mucociliari
epithelium
infect
ciliat
cell
apic
surfac
previou
studi
rsv
entri
employ
lipiddequench
assay
suggest
rsv
paramyxovirus
fuse
membran
directli
pm
target
cell
rsv
entri
phindepend
consist
view
hand
kolokoltsov
cowork
conclud
rsv
use
clathrinmedi
endocytosi
cme
infect
hela
cell
target
sirna
screen
reveal
clathrin
light
chain
import
cellular
factor
rsv
infect
recent
public
sanjuanvergara
et
al
argu
primari
nheb
cell
rsv
entri
twostep
process
rsv
dock
cholesterolrich
pm
domain
facilit
hemifus
viral
envelop
pm
follow
endocytosi
complet
fusion
endosom
determin
pathway
rsv
entri
hela
cell
develop
quantit
fluorescenceactiv
cell
sort
fac
assay
complement
confoc
microscopi
monitor
cell
bind
rsv
endocytosi
fusion
infect
test
effect
inhibitor
perturb
result
indic
rsv
infect
cell
endocytosismedi
mechan
fulfil
criteria
macropinocytosi
uptak
macropinosom
second
proteolyt
cleavag
f
serv
cue
penetr
membran
fusion
studi
use
recombin
rsv
strain
call
rgrsv
express
gfp
enabl
us
quantifi
infect
fac
viru
grown
cell
minim
exposur
broken
cell
harvest
cell
supernat
cytopath
effect
observ
qualiti
viru
purifi
gradient
centrifug
confirm
sdspage
fig
purifi
particl
examin
indirect
immunofluoresc
iif
use
antibodi
f
n
protein
found
three
differ
particl
popul
half
particl
repres
intact
virion
addit
f
green
contain
n
red
fig
also
stain
phalloidin
blue
pseudocolor
white
indic
presenc
actin
filament
previous
report
fig
arrowhead
remain
particl
constitut
capsidfre
envelop
vlp
stain
f
n
sinc
detect
free
capsid
would
stain
n
p
data
shown
use
presenc
capsid
antigen
distinguish
intact
rsv
vlp
purifi
viru
prepar
incub
hela
cell
immunoblot
sdspage
show
half
input
n
p
associ
cell
indic
rsv
bind
cold
effici
fig
measur
infect
rsv
ad
hela
cell
h
infect
continu
addit
h
measur
gfp
express
fac
fig
fraction
cell
respiratori
syncyti
viru
rsv
highli
pathogen
paramyxoviru
develop
assay
rsv
endocytosi
intracellular
traffick
membran
fusion
infect
result
show
rsv
rapidli
effici
intern
acidindepend
membran
fusion
occur
intracellularli
endocytosi
cell
biolog
studi
demonstr
endocytosi
macropinocyt
requir
infect
process
involv
activ
egf
receptor
downstream
effector
includ
myosin
ii
rsv
induc
transient
actin
rearrang
accompani
plasma
membran
bleb
elev
fluid
uptak
intern
intact
rsv
particl
larg
macropinosom
express
domin
neg
mutant
decreas
infect
indic
rsv
penetr
intracellular
take
place
posit
macropinosom
fusion
endolysosom
compart
reason
rsv
unlik
paramyxovirus
depend
endocyt
entri
found
need
activ
f
protein
second
proteolyt
cleavag
occur
endocytosi
involv
like
furinlik
vacuolar
enzym
gradient
purifi
rsv
ml
resolv
sdspage
follow
blue
silver
gel
stain
b
bind
glass
slide
purifi
rsv
stain
green
red
pseudocolor
white
particl
n
imag
confoc
microscop
analyz
coloc
imari
arrowhead
show
particl
three
stain
c
equal
volum
viru
input
moi
cell
bound
viru
lysat
unbound
viru
sup
resolv
sdspage
western
blot
develop
antip
antin
rsv
specif
antibodi
left
repres
western
blot
right
densitometri
quantif
pand
nprotein
band
intens
viru
input
cell
bound
viru
sampl
hela
cell
infect
rsv
moi
h
viru
inoculum
replac
medium
infect
carri
indic
time
percentag
infect
cell
express
gfp
measur
fac
express
gfp
increas
time
increas
multipl
infect
moi
cell
infect
moi
gfp
express
detect
earli
h
postinfect
hpi
gfp
posit
cell
hpi
cell
infect
moi
gfp
express
delay
h
follow
fate
cellbound
particl
cold
warm
iif
antif
antin
antibodi
use
actin
filament
label
phalloidin
visual
cell
boundari
confoc
zstack
imag
seri
orthogon
view
reveal
min
viru
particl
contain
n
f
present
cell
surfac
also
deep
insid
cytoplasm
fig
indic
viral
particl
vlp
endocytos
bind
cold
cellassoci
virus
vlp
remov
cell
surfac
brief
incub
trypsin
cold
affect
cell
attach
fig
min
found
cell
viru
bind
cold
incub
increas
fraction
cellassoci
particl
becam
trypsin
resist
fig
min
quantit
use
spot
detect
softwar
imari
show
min
vlp
rsvcontain
spot
fact
resist
trypsin
fig
total
number
rsvand
vlpcontain
spot
decreas
time
probabl
caus
accumul
multipl
particl
common
endocyt
vacuol
repres
singl
spot
antif
stain
spot
stain
n
indic
intact
virus
confirm
rsv
endocytos
intact
form
import
determin
whether
endocytos
particl
also
contain
viral
lipid
envelop
purifi
rsv
therefor
label
lipophil
fluoresc
dye
dioc
partit
viral
membran
fixabl
formaldehyd
quench
membraneimperm
dye
trypan
blue
tb
label
repurifi
particl
contain
detect
dioc
data
shown
ad
cell
incub
rsvdioc
particl
visibl
discret
fluoresc
spot
quench
tb
ad
fig
fac
analysi
show
fluoresc
resist
tb
min
full
resist
reach
min
fig
top
indic
intern
rsv
vlp
rapid
complet
importantli
intracellular
accumul
f
n
protein
measur
parallel
fig
bottom
intern
antigen
dioc
fig
top
follow
similar
kinet
monitor
fusion
rsv
cellular
membran
use
method
develop
sakai
cowork
case
rsv
label
two
fluoresc
lipid
red
dioc
green
concentr
use
quench
fluoresc
signal
emit
dioc
therefor
allow
bind
cell
view
live
confoc
microscopi
label
virus
initi
red
fig
min
howev
min
yellow
green
intracellular
spot
becam
appar
increas
number
time
fusion
two
lipid
dilut
green
fluoresc
dioc
longer
quench
fig
spot
show
ringlik
fluoresc
indic
dioc
local
limit
membran
intracellular
vacuol
quantit
fac
analysi
show
dequench
dioc
becam
detect
alreadi
min
fig
reach
half
maxim
level
min
plateau
min
treatment
cell
tb
fac
analysi
reveal
fluoresc
dioc
fail
quench
membran
imperm
agent
confirm
dioc
local
intracellular
organel
time
cours
appar
fusion
event
occur
averag
min
endocytosi
interpret
result
viru
particl
vlp
bound
cell
surfac
endocytos
endocytosi
rapid
effici
intern
virus
accumul
endocyt
vacuol
lag
period
viral
envelop
underw
fusion
vacuolar
membran
bring
infect
pictur
cell
viru
bound
cold
transfer
indic
time
place
ice
incub
trypsin
strip
away
surfaceattach
rsv
replat
incub
addit
hour
allow
infect
proceed
gfp
express
fac
analysi
demonstr
cultur
incub
trypsin
fraction
gfpexpress
cell
increas
time
maximum
infect
reach
within
min
half
time
around
min
fig
time
cours
coincid
perfectli
time
cours
viru
endocytosi
fig
impli
product
infect
depend
endocytosi
rsv
entri
infect
depend
endocytosi
indic
experi
expect
perturb
inhibit
endocytosi
block
intern
infect
experi
follow
endocytosi
rsv
quantifi
measur
amount
incom
n
protein
trypsin
resist
use
fac
analysi
h
warm
infect
score
percentag
cell
express
gfp
hpi
import
mention
dosedepend
fig
toxic
data
shown
inhibitor
care
determin
clariti
inhibitor
present
data
singl
concentr
found
strong
effect
low
cytotox
sinc
rsv
report
enter
cell
cme
hela
cell
test
five
cme
inhibitor
chlorpromazin
three
inhibitor
dynasor
none
influenc
rsv
endocytosi
although
intern
wellcharacter
cme
cargo
protein
transferrin
trf
effici
inhibit
fig
except
toxic
prolong
infect
assay
none
agent
inhibit
rsv
infect
fig
infect
semliki
forest
viru
sfv
viru
known
depend
cme
effici
block
fig
rsv
infect
report
insensit
increas
endosom
ph
confirm
lack
influenc
bafilomycin
ammonium
chlorid
monensin
rsv
infect
fig
expect
three
agent
block
infect
sfv
need
low
endosom
ph
trigger
fusion
small
reduct
rsv
infect
observ
ammonium
chlorid
monensin
may
reflect
import
balanc
vacuolar
environ
product
rsv
infect
taken
togeth
result
indic
rsv
endocytosi
infect
depend
cme
requir
acidif
rsv
bound
hela
cell
cold
cell
warm
rapid
dramat
chang
cell
shape
actin
distribut
observ
fig
number
actin
stress
fiber
decreas
cell
round
transient
bleb
fill
actin
form
cell
surfac
fig
min
chang
clearli
visual
live
cell
imag
movi
cell
morpholog
actin
distribut
return
normal
within
hpi
ratio
g
globular
f
fibrou
actin
determin
found
min
addit
rsv
ratio
g
f
actin
compar
control
cell
hela
cell
without
top
bound
rsv
moi
bottom
transfer
min
fixat
cell
process
confoc
microscopi
green
red
blue
zstack
imag
seri
acquir
orthogon
view
zstack
project
pseudocolor
white
gener
imagej
b
rsv
moi
bound
hela
cell
unbound
viru
remov
cell
transfer
indic
time
cell
place
ice
treat
pb
trypsin
min
pb
wash
vs
trypsin
treat
sampl
process
confoc
microscopi
c
quantif
imag
seri
repres
b
analysi
perform
imari
detect
spot
antif
stain
left
antif
n
stain
right
differ
time
warm
cell
disrupt
actin
filament
cytochalasin
latrunculin
well
filament
stabil
jasplakinolid
found
strongli
reduc
rsv
infect
wherea
sfv
infect
enhanc
fig
rsv
endocytosi
also
significantli
decreas
fig
inhibit
inhibit
rsv
infect
effect
inhibitor
rhoa
effector
rock
moder
effect
fig
infect
endocyt
uptak
reduc
downstream
effector
inhibit
includ
nwasp
wiskostatin
moder
target
fig
f
nocodazol
taxol
interfer
microtubul
effect
rsv
sfv
infect
fig
result
demonstr
actin
regul
play
critic
role
rsv
endocytosi
infect
factin
transient
depolymer
result
format
bleb
addit
nwasp
requir
rsv
intern
infect
format
bleb
involv
actin
role
suggest
infecti
entri
rsv
occur
macropinocytosi
recent
shown
sever
virus
review
see
one
characterist
featur
macropinocytosi
elev
uptak
extracellular
fluid
inde
serumstarv
hela
cell
expos
rsv
observ
intern
kda
solubl
fluoresc
tracer
ad
medium
increas
low
high
moi
respect
mock
treat
cell
fig
elev
significantli
higher
serumstimul
cell
iif
show
major
endocytos
virus
stain
antif
p
antibodi
local
larg
fill
intracellular
vacuol
fig
macropinosom
format
requir
na
h
exchang
nhe
activ
modul
rho
gtpase
pm
inhibit
nhe
eipa
amilorid
deriv
becom
one
diagnost
criteria
macropinocytosi
eipa
inhibit
rsv
intern
infect
fig
addit
pretreat
cell
eipa
block
increas
fluid
phase
uptak
induc
rsv
fig
taken
togeth
result
demonstr
rsv
induc
macropinocytosi
use
viru
endocytosi
infect
macropinocytosi
usual
initi
activ
receptor
tyrosin
kinas
rtk
integrin
follow
activ
spectrum
cellular
signal
factor
accordingli
found
rsv
infect
significantli
decreas
two
broad
rang
protein
kinas
inhibitor
staurosporin
serthr
kinas
multitarget
protein
tyrosin
kinas
inhibitor
genistein
fig
test
whether
rtk
involv
use
human
phosphortk
array
compris
antibodi
differ
phosphoryl
rtk
lysat
cell
expos
rsv
min
lysat
mocktreat
control
cell
use
probe
epiderm
growth
factor
receptor
egfr
rtk
activ
detect
fivefold
increas
phosphoryl
compar
control
fig
egfr
deplet
use
sirna
greater
reduct
infect
observ
fig
found
moreov
egfr
inhibitor
iressa
significantli
decreas
rsv
infect
fig
inhibit
wortmannin
downstream
effector
egfr
also
reduc
infect
fig
egfr
inhibitor
littl
effect
sfv
inhibitor
boost
sfv
infect
consist
distinct
entri
mechan
viru
addit
inhibit
pkc
rottlerin
calphostin
c
decreas
rsv
fig
although
effect
sfv
smaller
suggest
role
pkc
entri
virus
final
sinc
nonmuscl
myosin
ii
thought
mediat
closur
macropinosom
test
effect
myosin
ii
inhibitor
blebbistatin
myosin
light
chain
kinas
inhibitor
serum
starv
hela
cell
incub
fc
purifi
rsv
moi
h
inoculum
replac
medium
contain
kda
transfer
min
fixat
mfi
measur
fac
b
purifi
rsv
moi
bound
serumstarv
hela
cell
input
viru
replac
medium
contain
kda
green
transfer
indic
time
cell
fix
permeabil
stain
red
blue
antibodi
imag
repres
zstack
project
acquir
confoc
microscop
set
c
hela
cell
pretreat
solvent
mock
eipa
indic
concentr
left
cell
infect
rsv
moi
hour
fac
analysi
gfp
express
cell
right
rsv
moi
bound
cell
follow
h
intern
cell
trypsin
fix
stain
antibodi
mfi
measur
fac
serum
starv
hela
cell
pretreat
eipa
indic
concentr
incub
purifi
rsv
moi
viru
control
inoculum
replac
medium
contain
kda
eipa
transfer
min
cell
fix
mfi
measur
fac
reduc
rsv
infect
littl
effect
sfv
fig
inhibitor
decreas
infect
also
reduc
rsv
endocytosi
fig
bottom
depend
compound
rsv
intern
reduc
none
inhibitor
affect
rsv
cell
bind
fig
thu
conclud
infecti
rsv
cell
entri
endocytosi
associ
activ
egfr
downstream
signal
partner
includ
pkc
combin
requir
myosin
ii
find
consist
product
rsv
intern
macropinocytosi
addit
perform
seri
experi
cell
fig
reveal
chang
actin
morpholog
polymer
addit
rsv
role
egfr
nhe
factor
similar
hela
cell
rsv
infect
intern
infect
clearli
depend
cellular
process
factor
cell
indic
entri
macropinocytosi
hela
cell
specif
intracellular
traffick
macropinosom
well
character
shown
like
endosom
acidifi
acquir
follow
fuse
endolysosom
wild
type
wt
well
variou
constitut
activ
ca
domin
neg
dn
mutant
rab
transient
express
hela
cell
min
post
warm
observ
incom
rsv
coloc
wt
posit
vacuol
fig
coloc
even
evid
cell
express
ca
mutant
exhibit
enlarg
vacuol
fail
undergo
matur
detect
coloc
time
min
coloc
wt
still
observ
cell
express
dn
note
accumul
fand
pstain
particl
insid
larg
vacuol
perinuclear
space
coloc
rsv
wt
also
detect
determin
whether
play
role
infect
infect
cell
express
gfptag
construct
mutant
determin
fraction
infect
cell
among
cell
express
gfptag
rab
stain
cell
fac
analysi
reveal
dn
gfp
rab
construct
caus
signific
decreas
rsv
infect
overexpress
fig
confirm
result
imag
rrrsv
express
red
fluoresc
protein
fig
togeth
imag
data
result
indic
rsv
depend
gtp
infect
requir
infecti
penetr
thu
like
determin
earli
stage
macropinosom
matur
noteworthi
express
ca
known
gener
enlarg
endosom
prevent
endosom
matur
traffick
lysosom
affect
infect
pretreat
cell
pikfyv
inhibitor
ca
effect
rsv
infect
sfv
infect
decreas
fig
gener
ptdin
pikfyv
involv
matur
endosom
macropinosom
suggest
full
matur
macropinosom
requir
rsv
result
demonstr
pinch
pm
macropinosom
contain
rsv
acquir
later
matur
macropinosom
involv
evid
critic
step
infect
wherea
later
stage
matur
coordin
pikfyv
essenti
sinc
acidif
macropinosom
need
infect
specul
rsv
requir
intracellular
cue
trigger
fusion
f
uniqu
among
paramyxoviru
fusion
protein
two
cleavag
site
furinlik
proteas
gener
addit
kda
respect
solubl
amino
acid
aa
peptid
peptid
locat
ntermin
fusion
peptid
fig
hypothes
remov
peptid
endocytosi
might
requir
activ
f
protein
experi
cell
pretreat
membran
permeabl
furin
inhibitor
decrvkrcmk
prior
addit
rsv
indic
proteas
inde
involv
decrvkrcmk
treatment
reduc
infect
fig
membran
imperm
furin
inhibitor
apdx
effect
infect
suggest
activ
proteolysi
occur
cell
surfac
broad
rang
proteas
inhibitor
leupeptin
serin
cystein
threonin
proteas
caus
slight
increas
infect
inhibit
infect
decrvkrcmk
involv
f
protein
confirm
use
recombin
viru
strain
rsvdshdg
lack
sh
g
glycoprotein
infect
mutant
viru
also
block
decrvkrcmk
fig
decrvkrcmk
inhibitor
appli
h
viru
inocul
inhibit
indic
critic
proteolyt
step
coincid
entri
fig
fusion
assay
label
rsv
rsvdshdg
reveal
decrvkrcmk
impair
viral
fusion
fig
inhibitori
effect
compar
effect
eipa
block
viru
intern
fig
confirm
presenc
peptid
purifi
viru
use
target
mass
spectrometri
approach
base
select
reaction
monitor
srm
fig
neg
control
analyz
cell
extract
use
produc
viru
trypsin
digest
viru
prepar
detect
peptid
correspond
aa
f
protein
span
peptid
fig
neither
peptid
present
control
sampl
srm
transit
target
peptid
includ
support
inform
tabl
final
sdspage
use
monitor
chang
f
protein
entri
blot
antibodi
reveal
protein
band
isol
viru
migrat
molecular
weight
kda
confirm
f
protein
cleav
least
alreadi
produc
cell
fig
viru
bound
cell
cold
allow
cell
enter
h
mobil
cellassoci
becam
faster
kda
indic
process
occur
reduct
size
around
kda
consist
loss
n
terminu
importantli
cell
pretreat
decrvkrcmk
process
kda
protein
occur
expect
apdx
leupeptin
influenc
process
step
time
cours
process
follow
observ
process
detect
alreadi
min
cell
warm
fig
peak
min
precursor
fulli
consum
amount
protein
gradual
decreas
later
time
point
probabl
due
lysosom
degrad
explain
decreas
band
intens
endocytosi
lane
fig
hela
cell
pretreat
decrvkrcmk
pdx
leupeptin
indic
concentr
h
experi
inhibitor
continu
present
follow
step
experi
cell
infect
rsv
rsvdgdsh
h
fac
analysi
gfp
express
cell
b
hela
cell
infect
rsv
rsvdgdsh
h
viru
inoculum
replac
medium
contain
mm
decrvkrcmk
incub
fac
analysi
gfp
express
cell
c
versen
detach
hela
cell
pretreat
solvent
mock
decrvkrcmk
eipa
indic
concentr
inhibitor
continu
present
follow
step
experi
moi
bound
cell
unbound
viru
remov
cell
incub
h
presenc
inhibitor
cell
fix
mfi
dioc
fluoresc
measur
fac
normal
mock
inhibitor
control
rsv
f
protein
aa
proteolyt
process
furin
like
proteas
two
site
b
gener
disulfid
bond
link
small
peptid
aa
sequenc
depict
nterminu
fp
fusion
peptid
cterminu
tm
transmembran
domain
number
indic
aa
posit
red
underlin
specifi
peptid
sequenc
detect
mass
spectrometri
e
proteom
analysi
cell
purifi
rsv
particl
ntermin
sequenc
peptid
f
protein
quantifi
target
mass
spectrometri
base
select
reaction
monitor
srm
repres
srm
peak
peptid
left
fmnytlnnakktnvtlsk
right
elprfmnytlnnak
peptid
correspond
aa
f
protein
respect
differ
srm
transit
peptid
shown
differ
color
see
support
inform
tabl
bar
graph
show
result
target
peptid
quantit
present
sum
area
srm
peak
given
peptid
peptid
peak
detect
nois
valu
report
refer
rt
retent
time
cp
count
per
second
f
hela
cell
pretreat
mock
treat
decrvkrcmk
apdx
leupeptin
indic
concentr
rsv
input
control
first
line
bound
h
cold
bbind
washaway
unbound
viru
intern
h
process
iintern
lyse
cell
sampl
resolv
sdspage
blot
probe
antibodi
g
rsv
bound
h
cold
hela
cell
unbound
viru
wash
away
cell
place
indic
time
lysi
sdspage
process
western
blot
probe
antibodi
result
indic
becom
fusion
compet
infecti
protein
underw
second
highli
effici
cleavag
furinlik
convertas
endocyt
compart
time
cours
indic
process
occur
soon
endocytosi
preced
fusion
min
address
whether
result
appli
cell
type
infect
rsv
vivo
test
polar
epitheli
cell
obtain
human
bronchial
biopsi
day
cultur
distribut
tight
junction
marker
show
cell
reach
polar
phenotyp
fig
make
certain
rsv
could
infect
cell
apic
side
fig
test
effect
nine
diagnost
inhibitor
previous
use
hela
cell
experi
fig
inhibit
dynamin
macropinocytosi
furin
proteas
rsv
infect
quantifi
imagebas
approach
detect
fraction
gfpexpress
cell
agreement
find
hela
cell
inhibit
dynamin
dynasor
effect
rsv
infect
cell
even
boost
infect
eipa
seven
inhibitor
macropinocytosi
decreas
infect
dosedepend
fashion
indic
macropinocytosi
involv
entri
need
process
confirm
decrvkrcmk
found
decreas
infect
much
paramyxovirus
gener
thought
infect
cell
fuse
directli
pm
paramyxoviru
particl
also
endocytos
howev
also
clear
recent
document
sendai
nipah
rsv
newcastl
diseas
virus
lentiviru
vector
pseudotyp
measl
viru
glycoprotein
two
pathway
fusion
pm
fusion
endocytosi
lead
infect
clear
experi
found
intact
rsv
rapidli
effici
endocytos
capsid
glycoprotein
lipid
envelop
intact
rsv
capsidfre
vlp
accumul
within
cytoplasm
vacuol
half
time
min
follow
fusion
vacuol
half
time
around
min
sensit
fusion
assay
use
fluoresc
virus
show
fusion
occur
intracellularli
fusion
virus
pm
detect
format
syncytia
fusionfromwithout
observ
even
expos
cell
high
moi
data
shown
signific
delay
rsv
intern
fusion
could
least
part
explain
requir
postendocyt
cleavag
f
protein
perturb
inhibit
endocyt
uptak
caus
dramat
reduct
infect
confirm
role
endocytosi
infect
eipa
inhibit
endocytosi
infect
similar
level
inhibit
observ
agent
interf
actin
dynam
varieti
kinas
myosin
ii
inhibitori
effect
dn
express
also
consist
role
endocytosi
infecti
entri
proteolyt
activ
f
protein
necessari
fusion
infect
occur
intracellular
compart
conclud
rsv
vlp
effici
endocytos
penetr
membran
fusion
occur
endocyt
vacuol
least
infect
caus
endocytos
virus
endocyt
mechan
respons
entri
macropinocyt
demonstr
follow
observ
observ
satisfi
main
criteria
current
use
defin
macropinocytosi
inhibitor
studi
perform
use
polar
physiolog
relev
epitheli
cell
human
bronchial
epithelium
cell
infecti
entri
rsv
found
depend
actin
cytoskeleton
cell
signal
furinlik
proteas
activ
also
observ
hela
cell
result
indic
infect
polar
epitheli
cell
monolay
deriv
human
bronchial
tissu
involv
macropinocytosi
proteolyt
activ
f
protein
macropinocytosi
clathrinindepend
mechan
uptak
fluid
cellassoci
particl
within
larg
uncoat
vesicl
form
pm
cell
type
transient
induc
activ
rtk
downstream
signal
factor
recent
year
sever
virus
shown
use
infecti
cell
entri
recent
review
bestdescrib
exampl
includ
larg
virus
vaccinia
ebola
adeno
kaposi
sarcomaassoci
virus
interestingli
nipah
viru
paramyxoviru
henipaviru
subfamili
also
belong
group
use
receptor
phosphoryl
requir
macropinocyt
intern
infect
cell
found
egfr
phosphoryl
activ
rsv
inhibitor
iressa
target
receptor
block
endocytosi
infect
noteworthi
iressa
inhibitori
present
first
hour
viru
cell
contact
confirm
effect
entryspecif
data
shown
egfr
deplet
use
sirna
infect
decreas
suggest
rtk
may
abl
compens
longterm
experi
downstream
effector
egfr
pkc
also
import
rsv
endocytosi
infect
infect
previous
shown
promot
cell
surviv
mediat
cell
activ
phosphoryl
effector
akt
occur
within
min
rsv
addit
interestingli
also
demonstr
rsv
bind
nheb
cell
induc
pkca
phosphoryl
transloc
pm
inhibit
pkca
confirm
block
rsv
uptak
infect
result
contradict
previou
report
propos
rsv
entri
hela
cell
occur
cme
author
base
interpret
hit
clathrin
associ
protein
target
sirna
silenc
screen
factor
involv
endocytosi
hit
also
includ
actin
modul
function
entri
address
howev
sinc
readout
infect
h
role
cme
postendocyt
step
rsv
infecti
cycl
could
exclud
experi
observ
inhibit
rsv
endocytosi
infect
five
differ
agent
block
cme
chlorpromazin
dynasor
importantli
agent
effici
inhibit
sfv
viru
enter
via
cme
dynasor
fail
inhibit
rsv
infect
also
recent
report
other
macropinosom
still
poorli
character
evid
undergo
matur
process
similar
endosom
involv
acidif
associ
fusion
late
endosom
endolysosom
note
vacuol
contain
rsv
fact
later
overexpress
dn
mutant
inhibit
infect
suggest
rsv
penetr
requir
passag
earli
macropinosom
contain
lack
inhibit
mutant
pikfyv
inhibitor
nocodazol
known
inhibit
vacuolar
matur
impli
macropinosom
matur
beyond
posit
stage
necessari
final
result
provid
like
molecular
explan
endocytosi
requir
exhibit
rsv
unlik
paramyxovirus
f
protein
rsv
two
activ
cleavag
site
mass
spectroscopi
analysi
western
blot
show
f
isol
viru
cleav
asit
rarr
gener
cleav
ctermin
b
site
kkrkr
second
cleavag
occur
endocytosi
inhibit
second
cleavag
decrvkrcmk
inhibit
rsv
fusion
infect
decrvkrcmk
furin
inhibitor
suggest
proteas
question
belong
furin
famili
convertas
enzym
evid
acidindepend
activ
earli
posit
macropinosom
cleavag
b
site
like
import
remov
peptid
cap
nterminu
hydrophob
fusion
peptid
render
ntermin
sequenc
class
viral
fusion
protein
includ
paramyxoviru
f
protein
fusion
sequenc
invari
ntermin
conclus
confirm
rsv
requir
two
cleavag
f
protein
infect
show
second
cleavag
occur
cell
entri
infecti
entri
depend
endocytosi
viru
induc
transient
activ
macropinocytosi
viru
like
meet
enzym
gener
second
cleavag
posit
macropinosom
fusion
occur
delay
vacuol
respect
viru
resembl
ebola
sar
virus
fusion
protein
also
activ
within
endocyt
vacuol
proteas
interest
note
f
nipah
viru
singl
monobas
cleavag
site
f
activ
endocyt
uptak
cathepsin
inhibitor
cathepsin
block
infect
cathepsin
doubl
knockout
cell
infect
infecti
entri
paramyxovirus
virus
phindepend
membran
fusion
may
thu
endocytosisdepend
mechan
complex
previous
assum
rsv
import
analyz
molecular
featur
entri
process
detail
identifi
proteas
determin
whether
intracellular
rout
relev
also
vivo
induc
highli
regul
macropinocyt
process
may
prove
amen
inhibit
endocyt
mechan
therefor
easili
target
therapeut
hela
cell
obtain
atcc
cultur
dmem
supplement
fetal
calf
serum
fc
mm
hepe
glutamax
invitrogen
transform
bronchial
epitheli
cell
obtain
dr
gruenert
grown
rpmi
medium
supplement
fc
lglutamin
nea
least
day
infect
recombin
sfvzsgreen
stock
kindli
provid
dr
g
balistreri
purchas
atcc
recombin
rsv
strain
express
gfp
rgrsv
rgrsvdshdg
rfp
rrrsv
kindli
provid
dr
peepl
p
collin
rsv
produc
cell
viru
collect
form
cell
cultur
supernat
inhibitor
use
includ
alexi
biochem
dynasor
ascent
scientif
chembridg
wiskostatin
enzo
ca
ca
decrvkrcmk
staurosporin
taxol
wortmannin
apdx
calbiochem
bafilomycin
blebbistatin
calphostin
c
chlorpromazin
cytochalasin
eipa
genistein
jasplakinolid
latrunculin
leupeptin
monensin
nocodazol
rottlerin
sigma
antibodi
fluoresc
dye
use
compris
antin
monoclon
antirsv
goat
polyclon
millipor
antif
monoclon
abcam
antip
rabbit
polyclon
bioscienc
menlo
park
usa
goat
antimous
goat
antirabbit
donkey
antigoat
afconjug
kda
phalloidin
afconjug
dioc
molecular
probe
goat
antimous
goat
antirabbit
hrpconjug
biorad
express
plasmid
encod
gfptag
mutant
kindli
provid
dr
zerial
max
planck
institut
dresden
germani
cell
confluent
flask
infect
rsv
moi
ml
serum
free
dmemhep
medium
dmem
mm
hepe
h
inoculum
replac
complet
medium
dmem
fc
glutamax
mm
hepe
h
cell
supernat
collect
clarifi
centrifug
aliquot
snap
frozen
store
experi
requir
purifi
viru
viru
purif
method
ueba
modifi
follow
preclear
cell
supernat
centrifug
rpm
min
ti
rotor
beckman
optima
ultracentrifug
ml
wv
sucros
cushion
hbsshepe
buffer
hbss
mm
hepe
pellet
gentli
wash
reconstitut
sucros
centrifug
sucros
step
gradient
rpm
min
rotor
beckman
optima
ultracentrifug
opalesc
viru
band
collect
interfac
overlaid
continu
sucros
gradient
centrifug
rpm
h
rotor
beckman
optima
ultracentrifug
viru
fraction
sucros
harvest
dilut
hbsshepe
pellet
addit
centrifug
rpm
min
rotor
beckman
optima
ultracentrifug
viru
pellet
resuspend
hbsshepe
snap
frozen
store
rsv
stock
titer
infect
cell
serial
dilut
viru
well
plate
infect
allow
proceed
h
fix
cell
assess
microscopi
gfp
express
stain
rsv
antin
antibodi
detect
infect
cell
rgrsv
respect
protein
assay
biorad
use
measur
amount
protein
influenc
pharmacolog
inhibitor
test
cell
preincub
medium
contain
inhibitor
min
viru
bind
infect
except
rho
gtpase
proteas
inhibitor
requir
h
preincub
preincub
min
inhibitori
compound
indic
concentr
continu
present
step
infect
intern
experi
dioc
mg
ad
freshli
purifi
rsv
mg
ml
hbsshepe
buffer
incub
room
temperatur
gentli
shake
h
remov
unincorpor
dye
viru
filter
mm
syring
filter
millipor
snap
frozen
ml
aliquot
store
use
within
week
label
rsvdioc
titer
cell
describ
rsvdioc
endocytosi
assay
cell
detach
versen
solut
mm
edta
ph
wash
pb
chill
ice
purifi
rsvdioc
dilut
dmemhep
bound
cell
ice
h
inoculum
wash
away
pb
cell
resuspend
complet
medium
transfer
desir
time
cell
fix
formaldehyd
wash
resuspend
fac
buffer
pb
fc
mm
edta
fac
data
acquisit
bd
bioscienc
canto
ii
sampl
divid
two
one
sampl
acquir
directli
addit
trypan
blue
final
concentr
invitrogen
altern
intern
cell
treat
trypsin
min
ice
wash
pb
fix
formaldehyd
permeabil
triton
stain
antif
antin
antibodi
night
follow
secondari
antibodi
stain
mean
fluoresc
intens
measur
flow
cytometri
bd
bioscienc
canto
ii
normal
mock
control
without
bound
viru
purifi
rsv
mg
resuspend
ml
hbsshepe
buffer
ad
dioc
mm
mm
mixtur
label
perform
h
room
temperatur
gentli
shake
remov
unincorpor
dye
viru
filter
mm
syring
filter
millipor
use
freshli
fusion
assay
fusion
assay
cell
detach
versen
solut
wash
pb
chill
ice
purifi
dilut
dmemhep
bound
cell
ice
h
inoculum
wash
away
pb
cell
resuspend
complet
medium
transfer
desir
time
cell
fix
formaldehyd
wash
resuspend
fac
buffer
fac
data
acquisit
bd
bioscienc
canto
ii
sampl
divid
two
one
sampl
analyz
directli
addit
trypan
blue
final
concentr
invitrogen
rsv
moi
bound
subconflu
cell
h
cell
wash
pb
supplement
medium
contain
mm
cycloheximid
incub
h
cell
move
ice
treat
ice
cold
trypsin
min
wash
pb
fix
formaldehyd
permeabil
triton
stain
antin
antibodi
night
follow
goat
antimous
af
stain
mfi
mean
fluoresc
intens
af
stain
determin
fac
bd
bioscienc
canto
ii
analyz
mgml
intern
perform
parallel
ident
condit
except
uptak
carri
min
adher
cell
detach
versen
solut
wash
pb
chill
ice
pellet
cell
pellet
resuspend
dmemhep
contain
viru
inoculum
incub
h
effect
inhibitor
test
cell
preincub
media
contain
inhibitor
min
inhibitor
continu
present
step
experi
cell
wash
pb
remov
unbound
viru
fix
formaldehyd
permeabil
triton
stain
rsv
antif
night
follow
secondari
antibodi
label
sampl
reconstitut
fac
buffer
analyz
flow
cytometri
bd
bioscienc
canto
ii
mean
fluoresc
intens
valu
normal
mock
control
without
bound
viru
cell
detach
versen
solut
wash
pb
chill
ice
pellet
viru
input
purifi
viru
stock
moi
dilut
dmemhep
divid
two
portion
one
mix
cell
left
analysi
viru
input
viru
incub
cell
h
cell
pellet
centrifug
supernat
collect
unbound
virus
sampl
cell
pellet
wash
pb
resuspend
dmemhep
equal
volum
collect
supernat
sdspage
load
buffer
ad
sampl
follow
denatur
min
equal
volum
sampl
separ
sdspage
subject
western
blot
antip
antin
antibodi
western
blot
quantifi
densitometri
quantityon
softwar
biorad
subconflu
cell
seed
well
plate
starv
night
serum
free
dmemhep
medium
purifi
rsv
bound
prechil
cell
h
viru
inoculum
wash
cell
puls
serum
free
dmemhep
medium
contain
kda
mgml
min
cell
wash
mm
naoac
mm
nacl
ph
follow
pb
wash
cell
trypsin
fix
formaldehyd
analyz
flow
cytometri
bd
bioscienc
canto
ii
confoc
microscopi
cell
fix
formaldehyd
permeabil
triton
stain
rsv
specif
antibodi
imag
acquir
zeiss
laser
scan
confoc
microscop
transfect
cell
trypsin
pellet
electropor
mg
plasmid
dna
use
amaxa
nucleofactor
solut
r
program
cell
seed
mm
cover
glass
well
plate
imag
well
plate
fac
analysi
experi
perform
h
transient
express
experi
perform
accord
protocol
provid
fg
actin
vitro
assay
kit
produc
cytoskeleton
inc
cat
brief
subconflu
cell
cm
dish
inocul
purifi
rgrsv
moi
min
cell
wash
lyse
clarifi
centrifug
supernat
centrifug
rpm
h
rotor
beckman
optima
tlx
ultracentrifug
result
supernat
collect
gactin
pellet
factin
resuspend
equal
supernat
volum
water
contain
actin
depolymer
reagent
provid
kit
equal
volum
sampl
resolv
sdspage
western
blot
develop
antiactin
antibodi
measur
ratio
g
f
actin
western
blot
analyz
densitometri
quantityon
softwar
biorad
infect
assay
cell
plate
optic
bottom
well
plate
infect
rgrsv
hour
cell
fix
formaldehyd
counterstain
dapi
nine
imag
per
well
acquir
autom
microscop
autofocus
imag
acquisit
object
total
cell
number
number
infect
cell
express
gfp
score
matlabbas
infect
counter
softwar
describ
previous
human
phosphortk
array
kit
obtain
r
system
cat
experiment
procedur
follow
accord
manufactur
guidelin
brief
serumstarv
subconflu
cell
cm
dish
inocul
purifi
rsv
moi
null
viru
prep
extract
min
cell
lyse
preclarifi
centrifug
supernat
sampl
incub
antibodi
array
develop
provid
reagent
develop
array
analyz
densitometri
quantityon
softwar
biorad
subconflu
cell
well
plate
chill
ice
min
rsv
moi
dmemhep
bound
cell
h
post
bind
sampl
wash
lyse
ripa
buffer
mm
tri
mm
nacl
mm
edta
sd
ph
remain
sampl
wash
pb
supplement
complet
medium
transfer
h
follow
cell
trypsin
wash
lyse
ripa
buffer
sampl
separ
bistri
gel
invitrogen
western
blot
probe
antif
antibodi
hrp
conjug
goat
antmous
develop
super
signal
west
pico
pierc
immunofluoresc
stain
analysi
cell
seed
mm
coverslip
well
plate
h
prior
experi
plate
chill
ice
rsv
bound
cell
dmemhep
h
virus
wash
away
cell
supplement
complet
medium
transfer
desir
time
cell
fix
formaldehyd
permeabil
triton
incub
goat
serum
min
cell
stain
appropri
primari
secondari
antibodi
coverslip
mount
glass
slide
prolong
gold
antifad
reagent
invitrogen
immunofluoresc
imag
captur
lsm
zeiss
microscop
confoc
laser
scan
set
object
per
experi
imag
captur
process
imagej
viru
particl
detect
imari
softwar
use
set
detect
particl
larger
mm
qualiti
greater
live
cell
imag
perform
olympu
cellr
object
dic
set
equip
incub
cell
gradient
purifi
rsv
particl
lyse
denatur
buffer
contain
urea
mm
nh
hco
lysat
briefli
sonic
protein
reduc
mm
dtt
min
alkyl
mm
iodoacetamid
min
sampl
dilut
mm
nh
hco
digest
sequencinggrad
porcin
trypsin
promega
enzymesubstr
ratio
digest
perform
overnight
stop
formic
acid
final
concentr
peptid
mixtur
desalt
seppak
cartridg
water
elut
acetonitril
vacuum
centrifug
dryness
resuspend
formic
acid
peptid
mass
well
collis
energi
ce
peptid
fragment
calcul
use
skylin
maccoss
lab
softwar
doubl
tripl
charg
product
ion
yand
bseri
transit
mass
rang
da
consid
see
full
list
srm
transit
support
inform
tabl
peptid
sampl
measur
srm
mode
triplequadrupoleion
trap
mass
spectromet
absciex
equip
nanoelectrospray
ion
sourc
chromatograph
separ
peptid
instrument
coupl
eksig
nano
lc
system
absciex
connect
fuse
silica
column
mm
inner
diamet
bgb
analytik
pack
inhous
magic
aq
mm
bead
michrom
bioresourc
peptid
mixtur
load
autosampl
cool
absciex
separ
linear
gradient
acetonitril
water
contain
formic
acid
acetonitril
min
flow
rate
nlmin
srm
analysi
conduct
oper
unit
resolut
mz
half
maximum
peak
width
transit
per
run
dwell
time
ms
cycl
time
data
analyz
softwar
skylin
peak
area
srm
peak
use
quantit
confirm
coelut
shape
similar
transit
monitor
peptid
outlier
transit
eg
shoulder
noisi
transit
trace
consid
calcul
result
present
sum
area
srm
peak
given
peptid
experi
perform
least
triplic
present
normal
valu
standard
deviat
sd
rsv
moi
bound
cell
follow
min
cell
iif
green
red
pseudocolor
white
confoc
microscopi
zstack
imag
seri
acquir
orthogon
view
imag
zstack
pseudocolor
white
gener
imagej
b
rsv
moi
bound
cell
viru
inoculum
wash
cell
warm
fix
indic
time
stain
pseudo
color
white
red
antibodi
imag
repres
zstack
project
acquir
confoc
microscop
movi
rsv
induc
transient
bleb
hela
cell
hela
cell
inocul
purifi
rsv
moi
immedi
imag
olympu
cellr
microscop
dic
set
object
frame
per
sec
speed
avi
tabl
srm
assay
use
studi
uniprot
access
number
fushrsva
docx
